Back to Authors

Abella-Dominicis, Esteban

A5078138864 | I4210140816

Mayo Clinic

Gilead Sciences (United States)

Citations 1

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Blood | March 22, 2017 | Volume: 129 | Issue: 22 | Pages: 3037-3039

10.1182/blood-2016-12-757740 | PMID 28325864